Developer docs
API playgroundTry for free, no card

Search company profiles

Generation Lab

Full company profile

uuid0005zf2

Namestring
Generation Lab
Legal namestring
Generation Lab
Company typeenum
Private
Founded yearint
2023
Descriptiontext

Generation Lab is a longevity diagnostics company that sells the SystemAge biological age test, a one-time $490 cheek-swab/blood-based consumer and clinical diagnostic measuring 460+ biomarkers across 21 organ systems to quantify biological versus chronological aging. The product is delivered via a needle-free at-home blood collection device, paired with a personalized action plan and optional professional consultation and retesting, and is offered both direct-to-consumer through the company's website and through a network of 750+ affiliated clinics across 18 countries.

The underlying technology is an epigenetic and biomarker analysis platform informed by over 20 years of academic aging research from co-founder and Chief Science Officer Dr. Irina Conboy (UC Berkeley), including foundational work on aging reversal and DNA methylation biomarkers. The system is described as built on over 300 million human-aging data points and claims 99% accuracy across 1,605 test cases for the SystemAge 2.1 version released in June 2026. Generation Lab operates a hybrid business model: direct-to-consumer e-commerce via generationlab.com at $490 per test, plus a B2B2C distribution model where 750+ clinics purchase kits and resell testing to their patients. Distribution has expanded via strategic partnerships, most notably integration into the Samsung Health ecosystem (77 million monthly active users) announced at VivaTech 2026, and a Hall of Fame Health alliance for elite athletes and executives.

The company is venture-backed at $15 million in total disclosed funding, with an $11 million Accel-led seed round closed in October 2025 and an earlier undisclosed pre-seed from Transpose Platform and a Sequoia China founding partner in January 2024. The company was founded in 2023, launched out of stealth in 2024, employs 1-10 people, and is headquartered in Burlingame, California at a 12,300 sq ft life science campus. Co-founders Alina Su (CEO) and Michael Suswal (COO) lead the company alongside Dr. Conboy.

Short descriptiontext

Generation Lab sells the SystemAge biological age test, a $490 at-home diagnostic measuring 460+ biomarkers across 21 organ systems, sold direct-to-consumer and through 750+ clinics in 18 countries. The company targets health-conscious consumers, longevity clinics, and via Samsung Health integration, a global connected-care audience.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biological age testing, epigenetic diagnostics, longevity health diagnostics, biomarker blood testing, age assessment services
Industry3 codes
PRIMARYHLAAALAN
Laboratory Developed Tests (LDTs) & Specialized Clinical Lab Assays
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
SIC code2 codes
  • Services-Medical Laboratories8071
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Longevity Diagnostics
No data
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1SystemAge Test Kits
TypeOne Time License
Description

One-time purchase of biological age test kits sold directly to consumers through the website and through clinic partners. The test measures biological aging across multiple organ systems and provides a comprehensive aging report with personalized action plan.

generationlab.com
2Clinic/Provider Distribution
TypeOne Time License
Description

B2B2C model where the company provides test kits and platform access to clinics, which then offer tests to their patients. Clinics pay for platform access and pass the cost to consumers.

biospace.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1SystemAge Blood Test - $490 per test
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$490 per test, available through over 300 clinics in 18 countries. The test includes a comprehensive biological age report analyzing biomarkers and assessing aging across multiple organ systems.

biospace.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 2 records shown
1SystemAge
Description

Biological age diagnostic platform that measures over 460 biomarkers across 21 organ systems from a single blood sample. Offers dedicated male and female versions with sex-specific aging analysis.

pulse2.com
+1 more record
Core offering1 text field

Generation Lab offers the SystemAge biological age diagnostic platform that measures over 460 biomarkers across 21 organ systems from a single needle-free blood draw. The platform is delivered as an at-home test kit (priced at $490) with a 15-minute self-administered collection process, followed by a personalized SystemAge Report and action plan. The platform is also distributed through 750+ affiliated clinics across 18 countries that offer the test to their patients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 99.9% diagnostic accuracy (original SystemAge platform)
+5 more records
Product overview1 text field

Generation Lab offers SystemAge, a unified biological age testing platform with multiple integrated components. The core product is SystemAge 2.1, a biological age test measuring 460+ biomarkers across 21 organ systems from a single needle-free blood draw. The platform includes three supporting modules: (1) an At-Home Needle-Free Blood Collection device for 15-minute sample collection, (2) a SystemAge Report with Personalized Action Plan providing full-body aging insights and early health risk identification, and (3) optional Professional Consultation and Retesting services. The platform is backed by over 20 years of aging research from co-founder Prof. Irina Conboy, and is currently deployed in over 750 clinics across 18 countries.

Product and service1 record
1SystemAge 2.1
CategoryLongevity Diagnostics
Description

Biological age testing platform that measures over 460 biomarkers across 21 organ systems from a single needle-free blood draw. Includes sex-specific male and female versions with sex-specific aging analysis, validated with 99% accuracy across 1,605 test cases. Available for direct consumer purchase at $490 per test and through 750+ affiliated clinics in 18 countries. Delivered with a SystemAge Report and personalized action plan, plus optional professional consultation and retesting.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierMajorTypeTechnology or IntegrationAnnounced on2026-06-01
Description

Samsung announced partnership with Generation Lab as part of its connected health vision at VivaTech 2026. Generation Lab's biological age tracking integrates with Samsung Health ecosystem (77M monthly active users) and SmartThings (460M devices) for preventive health platform. Samsung opened its Health SDK Suite to developers for integration.

2Hall of Fame Health
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-02-01
Description

Strategic collaboration announced during Super Bowl LX Week to develop a regenerative and longevity platform combining Generation Lab's diagnostics with advanced treatments. Targets athletes, executives, and industry leaders with personalized longevity protocols.

prnewswire.com
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-02-01
Description

Partner in Hall of Fame Health's regenerative and longevity platform alongside Generation Lab and Beverly Hills Rejuvenation Center.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-02-01
Description

Partner in Hall of Fame Health's regenerative and longevity platform alongside Generation Lab and Regen Therapy.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Function Health
TypeDirect peer
Description

Function Health sells comprehensive annual blood-based diagnostics with personalized insights for health-conscious consumers. It is a direct competitor on consumer longevity diagnostics, breadth of biomarkers, and subscription-style testing cadence.

TypeDirect peer
Description

TruDiagnostic is a direct competitor offering epigenetic biological age testing (e.g., DunedinPACE, GrimAge) with a clinic and provider channel model, directly overlapping Generation Lab's SystemAge in product, customer, and delivery mechanism.

TypeDirect peer
Description

myDNAge offers epigenetic biological age testing based on DNA methylation, directly comparable to Generation Lab's SystemAge in scientific methodology, biomarker focus, and consumer target market.

TypeEmerging player
Description

Viome sells at-home health diagnostics (microbiome, transcriptomics) with personalized recommendations. It overlaps with Generation Lab in DTC health diagnostics, consumer personalization, and longevity-adjacent positioning, though biology differs.

TypeDirect peer
Description

InsideTracker offers personalized blood-based biomarker testing and wellness insights via DTC and B2B channels. It competes with Generation Lab on consumer longevity diagnostics, biomarker panels, and personalized action plans.

TypeOthers
Description

Zymo Research supplies epigenetics and nucleic acid research tools and services, including DNA methylation analysis. It is an enabling/adjacent player whose technology underpins biological age tests like Generation Lab's.

TypeBroad incumbent
Description

Thorne is an established health and wellness brand with at-home testing and supplements. It competes with Generation Lab as a broader incumbent offering diagnostics alongside supplements, capturing consumer longevity spend.

TypeDirect peer
Description

TallyHealth sells at-home biological age tests focused on aging biomarkers with consumer-facing longevity positioning. It is a direct peer on product, target buyer (health-conscious consumers), and go-to-market motion.

TypeDirect peer
Description

GlycanAge offers a direct-to-consumer biological age test based on glycan biomarkers, competing with Generation Lab on biological age testing accuracy, consumer branding, and clinic partnerships.

TypeDirect peer
Description

Elysium Index is a direct competitor that sells a biological age test based on epigenetic biomarkers to consumers, competing with SystemAge on accuracy claims, breadth of biomarkers, and direct-to-consumer longevity positioning.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors9 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Generation Lab

Longevity Diagnosticsgenerationlab.co

Generation Lab sells the SystemAge biological age test, a $490 at-home diagnostic measuring 460+ biomarkers across 21 organ systems, sold direct-to-consumer and through 750+ clinics in 18 countries. The company targets health-conscious consumers, longevity clinics, and via Samsung Health integration, a global connected-care audience.

What Generation Lab does

Generation Lab is a longevity diagnostics company that sells the SystemAge biological age test, a one-time $490 cheek-swab/blood-based consumer and clinical diagnostic measuring 460+ biomarkers across 21 organ systems to quantify biological versus chronological aging. The product is delivered via a needle-free at-home blood collection device, paired with a personalized action plan and optional professional consultation and retesting, and is offered both direct-to-consumer through the company's website and through a network of 750+ affiliated clinics across 18 countries.

The underlying technology is an epigenetic and biomarker analysis platform informed by over 20 years of academic aging research from co-founder and Chief Science Officer Dr. Irina Conboy (UC Berkeley), including foundational work on aging reversal and DNA methylation biomarkers. The system is described as built on over 300 million human-aging data points and claims 99% accuracy across 1,605 test cases for the SystemAge 2.1 version released in June 2026. Generation Lab operates a hybrid business model: direct-to-consumer e-commerce via generationlab.com at $490 per test, plus a B2B2C distribution model where 750+ clinics purchase kits and resell testing to their patients. Distribution has expanded via strategic partnerships, most notably integration into the Samsung Health ecosystem (77 million monthly active users) announced at VivaTech 2026, and a Hall of Fame Health alliance for elite athletes and executives.

The company is venture-backed at $15 million in total disclosed funding, with an $11 million Accel-led seed round closed in October 2025 and an earlier undisclosed pre-seed from Transpose Platform and a Sequoia China founding partner in January 2024. The company was founded in 2023, launched out of stealth in 2024, employs 1-10 people, and is headquartered in Burlingame, California at a 12,300 sq ft life science campus. Co-founders Alina Su (CEO) and Michael Suswal (COO) lead the company alongside Dr. Conboy.

Generation Lab firmographics

Firmographics
Name
Generation Lab
Legal name
Generation Lab
Website
https://generationlab.co
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
11–50 employees
Short description
Generation Lab sells the SystemAge biological age test, a $490 at-home diagnostic measuring 460+ biomarkers across 21 organ systems, sold direct-to-consumer and through 750+ clinics in 18 countries. The company targets health-conscious consumers, longevity clinics, and via Samsung Health integration, a global connected-care audience.
Ownership category
akta.pro rank

Generation Lab industry classification

Industry
Product category
Longevity Diagnostics
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
SIC
Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAAALAN
Laboratory Developed Tests (LDTs) & Specialized Clinical Lab Assays
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • Biological age testing
  • Epigenetic diagnostics
  • Longevity health diagnostics
  • Biomarker blood testing
  • Age assessment services

Where Generation Lab is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Generation Lab business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. SystemAge Test Kits: One-time purchase of biological age test kits sold directly to consumers through the website and through clinic partners. The test measures biological aging across multiple organ systems and provides a comprehensive aging report with personalized action plan.
  2. Clinic/Provider Distribution: B2B2C model where the company provides test kits and platform access to clinics, which then offer tests to their patients. Clinics pay for platform access and pass the cost to consumers.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goSystemAge Blood Test - $490 per test

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Generation Lab product offering

Product offering

Core offering

Generation Lab offers the SystemAge biological age diagnostic platform that measures over 460 biomarkers across 21 organ systems from a single needle-free blood draw. The platform is delivered as an at-home test kit (priced at $490) with a 15-minute self-administered collection process, followed by a personalized SystemAge Report and action plan. The platform is also distributed through 750+ affiliated clinics across 18 countries that offer the test to their patients.

Product overview

Generation Lab offers SystemAge, a unified biological age testing platform with multiple integrated components. The core product is SystemAge 2.1, a biological age test measuring 460+ biomarkers across 21 organ systems from a single needle-free blood draw. The platform includes three supporting modules: (1) an At-Home Needle-Free Blood Collection device for 15-minute sample collection, (2) a SystemAge Report with Personalized Action Plan providing full-body aging insights and early health risk identification, and (3) optional Professional Consultation and Retesting services. The platform is backed by over 20 years of aging research from co-founder Prof. Irina Conboy, and is currently deployed in over 750 clinics across 18 countries.

Differentiator

Problem solved

Functional benefit

Brands

  • SystemAge: Biological age diagnostic platform that measures over 460 biomarkers across 21 organ systems from a single blood sample. Offers dedicated male and female versions with sex-specific aging analysis.
  • SystemAge 2.1

Products and services

  • SystemAge 2.1 Biological age testing platform that measures over 460 biomarkers across 21 organ systems from a single needle-free blood draw. Includes sex-specific male and female versions with sex-specific aging analysis, validated with 99% accuracy across 1,605 test cases. Available for direct consumer purchase at $490 per test and through 750+ affiliated clinics in 18 countries. Delivered with a SystemAge Report and personalized action plan, plus optional professional consultation and retesting.

Quantifiable outcome

  • 99.9% diagnostic accuracy (original SystemAge platform)
  • +5 more outcomes

Companies that use Generation Lab

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Generation Lab technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability3 records

Feature7 records

Generation Lab partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered major.

  • SamsungmajorTechnology or Integration · 1 June 2026Samsung announced partnership with Generation Lab as part of its connected health vision at VivaTech 2026. Generation Lab's biological age tracking integrates with Samsung Health ecosystem (77M monthly active users) and SmartThings (460M devices) for preventive health platform. Samsung opened its Health SDK Suite to developers for integration.
  • Hall of Fame HealthmajorStrategic or Co-development Partner · 1 February 2026Strategic collaboration announced during Super Bowl LX Week to develop a regenerative and longevity platform combining Generation Lab's diagnostics with advanced treatments. Targets athletes, executives, and industry leaders with personalized longevity protocols.
  • Regen TherapymajorStrategic or Co-development Partner · 1 February 2026Partner in Hall of Fame Health's regenerative and longevity platform alongside Generation Lab and Beverly Hills Rejuvenation Center.
  • Beverly Hills Rejuvenation CentermajorStrategic or Co-development Partner · 1 February 2026Partner in Hall of Fame Health's regenerative and longevity platform alongside Generation Lab and Regen Therapy.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Generation Lab competitors and assessment

Company assessment

Direct peers

  • Function Health: Function Health sells comprehensive annual blood-based diagnostics with personalized insights for health-conscious consumers. It is a direct competitor on consumer longevity diagnostics, breadth of biomarkers, and subscription-style testing cadence.
  • TruDiagnostic: TruDiagnostic is a direct competitor offering epigenetic biological age testing (e.g., DunedinPACE, GrimAge) with a clinic and provider channel model, directly overlapping Generation Lab's SystemAge in product, customer, and delivery mechanism.
  • myDNAge: myDNAge offers epigenetic biological age testing based on DNA methylation, directly comparable to Generation Lab's SystemAge in scientific methodology, biomarker focus, and consumer target market.
  • InsideTracker: InsideTracker offers personalized blood-based biomarker testing and wellness insights via DTC and B2B channels. It competes with Generation Lab on consumer longevity diagnostics, biomarker panels, and personalized action plans.
  • TallyHealth: TallyHealth sells at-home biological age tests focused on aging biomarkers with consumer-facing longevity positioning. It is a direct peer on product, target buyer (health-conscious consumers), and go-to-market motion.
  • GlycanAge: GlycanAge offers a direct-to-consumer biological age test based on glycan biomarkers, competing with Generation Lab on biological age testing accuracy, consumer branding, and clinic partnerships.
  • Elysium Index: Elysium Index is a direct competitor that sells a biological age test based on epigenetic biomarkers to consumers, competing with SystemAge on accuracy claims, breadth of biomarkers, and direct-to-consumer longevity positioning.

Emerging players

  • Viome: Viome sells at-home health diagnostics (microbiome, transcriptomics) with personalized recommendations. It overlaps with Generation Lab in DTC health diagnostics, consumer personalization, and longevity-adjacent positioning, though biology differs.

Others

  • Zymo Research: Zymo Research supplies epigenetics and nucleic acid research tools and services, including DNA methylation analysis. It is an enabling/adjacent player whose technology underpins biological age tests like Generation Lab's.

Broad incumbents

  • Thorne: Thorne is an established health and wellness brand with at-home testing and supplements. It competes with Generation Lab as a broader incumbent offering diagnostics alongside supplements, capturing consumer longevity spend.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Generation Lab financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Generation Lab leadership team

Management profile

Number of profiles

Profiles3 records

Generation Lab funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Generation Lab M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Generation Lab

What does Generation Lab do?

Generation Lab offers the SystemAge biological age diagnostic platform that measures over 460 biomarkers across 21 organ systems from a single needle-free blood draw. The platform is delivered as an at-home test kit (priced at $490) with a 15-minute self-administered collection process, followed by a personalized SystemAge Report and action plan. The platform is also distributed through 750+ affiliated clinics across 18 countries that offer the test to their patients.

Is Generation Lab a public or private company?

Generation Lab is a private company. It is classified as venture growth investor backed and is currently operating.

When was Generation Lab founded?

Generation Lab was founded in 2023. It employs 11 to 50 people.

Where is Generation Lab based?

Generation Lab is headquartered in San Francisco, United States, in the North America region.

How does Generation Lab make money?

Two revenue lines are on record. SystemAge Test Kits are the primary driver. The others are clinic/Provider Distribution.

Who are Generation Lab's main competitors?

Direct peers on record are Function Health, TruDiagnostic, myDNAge, InsideTracker, TallyHealth, GlycanAge and Elysium Index. Viome is listed as an emerging player. Zymo Research is listed as an others. Thorne is listed as a broad incumbent.

Does Generation Lab have an API?

No public API is recorded for Generation Lab.

What industry is Generation Lab in?

Generation Lab's product category is Longevity Diagnostics. Its primary akta.pro industry code is HLAAALAN, Laboratory Developed Tests (LDTs) & Specialized Clinical Lab Assays, with a secondary code of HLAAALAL, Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Cool DownLongevity startup offers reporter a secret 2-drug shot meant to make blood youngerGeneration Lab is offering a secret injectable treatment to a select group, including MIT Technology Review reporter Antonio Regalado, claiming it can make blood stop aging. The company has not disclosed the two drugs, citing a desire to discourage copycats, and the treatment's support is mostly anecdotal. The company plans a larger study with at least 100 participants.MIT Technology ReviewA startup claims it’s found a drug to make your blood youngGeneration Lab, founded by UC Berkeley researcher Irina Conboy, is recruiting influencers for its injectable combination of two existing drugs, 1-Generation, which it says blocks the systemic spread of aging. The company will not disclose the drugs, plans a paid trial of over 100 people led by alternative-medicine doctors, and seeks FDA exclusivity.Longevity.TechnologyGeneration Lab launches at-home SystemAge test for sex-specific biological agingGeneration Lab has launched SystemAge, an at-home biological aging test that assesses aging across 21 body systems using sex-specific science focused on immune, cardiovascular, and metabolic aging in women. The platform provides lifestyle-linked insights, including guidance on optimal walking intensity and air travel's impact on biological aging, with Chief Science Officer Dr. Irina Conboy's 20+ years of aging research cited as scientific backing. Details on regulatory pathways and clinical validation for the platform remain limited.Samsung Mobile PressSamsung Highlights Open Ecosystem To Accelerate Connected Care for Daily Wellness at VivaTech 2026Samsung Electronics highlighted its vision for connected care through an open collaboration ecosystem during a panel discussion at VivaTech 2026 in Paris. The company showcased partnerships with Xealth, Generation Lab, and SiPhox Health to integrate diagnostic and wellness services into its SmartThings and Samsung Health platforms.Longevity.TechnologyGeneration Lab launches SystemAge 2.1 as the first gender-specific biological age testGeneration Lab announced the general availability of SystemAge 2.1 on June 25, 2026, in Burlingame, California, introducing what it claims is the first biological age test with dedicated female and male-specific versions, measuring over 460 biomarkers across 21 organ systems with 99% accuracy validated across 1,605 test cases. The platform, currently in use at more than 750 clinics across 18 countries, utilizes a Biological Noise metric based on DNA methylation analysis, which the company says outperforms existing clocks like DunedinPACE and PhenoAge in accuracy and clinical balance. The update adds new coverage for skin, connective tissue, reproductive system, and mitochondrial function, along with longitudinal trend views and per-organ tracking of treatment efficacy for interventions including NAD+, peptides, stem cells, therapeutic plasma exchange, and hormones.PR NewswireGeneration Lab Launches SystemAge™ 2.1, The First Biological Age Test with Female & Male-Specific VersionsGeneration Lab announced the general availability of SystemAge™ 2.1, a preventative health measurement platform and the first biological age test to offer dedicated female and male-specific versions, measuring 460+ biomarkers across 21 organ systems with 99% accuracy validated across 1,605 test cases. The new version adds sex-specific testing, new organ coverage for skin, reproductive system, and mitochondrial function, and a longitudinal trend view showing how patients age over time. The platform is currently deployed in over 750 clinics in 18 countries and is backed by Accel and Samsung.Pulse 2.0Generation Lab Launches SystemAge 2.1 Biological Age TestGeneration Lab announced the general availability of SystemAge 2.1, a biological age testing platform that measures over 460 biomarkers across 21 organ systems from a single needle-free blood draw. The new version is the first biological age test to offer dedicated male and female versions with sex-specific aging analysis, validated with 99% accuracy across 1,605 test cases. The platform, built on over two decades of aging research from co-founder Prof. Irina Conboy, is currently deployed in more than 750 clinics across 18 countries.NateSamsung Health users surpass 77 million... Presenting the future of AI healthcare at VivaTech: Nate NewsSamsung Electronics showcased its AI healthcare initiatives at the VivaTech 2026 conference in Paris, featuring a panel discussion on future health technologies. The event highlighted Samsung's broader digital health strategy alongside other industry leaders such as Cyfox and Generation Lab.